Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Brown Forman (BF-A) Cash & Equivalents (2016 - 2026)

Brown Forman (BF-A) has disclosed Cash & Equivalents for 18 consecutive years, with $383.0 million as the latest value for Q1 2026.

  • Quarterly Cash & Equivalents fell 36.06% to $383.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $383.0 million through Jan 2026, down 36.06% year-over-year, with the annual reading at $444.0 million for FY2025, 0.45% changed from the prior year.
  • Cash & Equivalents for Q1 2026 was $383.0 million at Brown Forman, up from $319.0 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $1.1 billion in Q4 2022, with the low at $319.0 million in Q4 2025.
  • Average Cash & Equivalents over 5 years is $550.0 million, with a median of $444.0 million recorded in 2025.
  • The sharpest move saw Cash & Equivalents crashed 65.69% in 2023, then surged 37.62% in 2024.
  • Over 5 years, Cash & Equivalents stood at $1.1 billion in 2022, then plummeted by 65.69% to $373.0 million in 2023, then grew by 11.53% to $416.0 million in 2024, then decreased by 23.32% to $319.0 million in 2025, then grew by 20.06% to $383.0 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $383.0 million, $319.0 million, and $471.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.